Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article Full Text Full Text (PDF, 103K) PPT slides of all figures Alert me when this article is cited Citation Map Services Email this article Similar articles in this journal Similar articles in PubMed Alert me to new content in the JEM Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Kammer, A. R. Articles by Cerny, A. Search for Related Content PubMed PubMed Citation Articles by Kammer, A. R. Articles by Cerny, A. Social Bookmarking                            What's this?

Original Article

^a From the Department of Internal Medicine, University Hospital, Inselspital, 3010 Bern, Switzerland
^b Department of Immunohematology and Blood Bank, Leiden University Medical Center, 2300 RC Leiden, The Netherlands
^c Institute of Clinical Pharmacology, University Hospital, Inselspital, 3010 Bern, Switzerland
Department of Internal Medicine, University Hospital, Inselspital, 3010 Bern, Switzerland.41-31-632-964641-31-632-2111

cerny{at}insel.ch

Hepatitis C virus (HCV) is thought to be involved in the pathogenesis of autoimmune hepatitis (AIH) type 2, which is defined by the presence of type I antiliver kidney microsome autoantibodies directed mainly against cytochrome P450 (CYP)2D6 and by autoreactive liver infiltrating T cells. Virus-specific CD8⁺ cytotoxic T lymphocytes (CTLs) that recognize infected cells and contribute to viral clearance and tissue injury during HCV infection could be involved in the induction of AIH. To explore whether the antiviral cellular immunity may turn against self-antigens, we characterized the primary CTL response against an HLA-A*0201–restricted HCV-derived epitope, i.e., HCV core 178–187, which shows sequence homology with human CYP2A6 and CYP2A7 8–17. To determine the relevance of these homologies for the pathogenesis of HCV-associated AIH, we used synthetic peptides to induce primary CTL responses in peripheral blood mononuclear cells of healthy blood donors and patients with chronic HCV infection. We found that the naive CTL repertoire of both groups contains cross-reactive CTLs inducible by the HCV peptide recognizing both CYP2A6 and CYP2A7 peptides as well as endogenously processed CYP2A6 protein. Importantly, we failed to induce CTLs with the CYP-derived peptides that showed a lower capacity to form stable complexes with the HLA-A2 molecule. These findings demonstrate the potential of HCV to induce autoreactive CD8⁺ CTLs by molecular mimicry, possibly contributing to virus-associated autoimmunity.

Key Words: hepatitis C-like viruses • autoimmunity • hepatitis, autoimmune • HLA-A2 antigen • antigens, viral

This work was presented in part at the 5th International Meeting on Hepatitis C Virus and Related Viruses in Venice, Italy, June 25–28, 1998.

© 1999 The Rockefeller University Press

CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

• Holdener, M., Hintermann, E., Bayer, M., Rhode, A., Rodrigo, E., Hintereder, G., Johnson, E. F., Gonzalez, F. J., Pfeilschifter, J., Manns, M. P., Herrath, M. v. G., Christen, U. (2008). Breaking tolerance to the natural human liver autoantigen cytochrome P450 2D6 by virus infection. JEM 205: 1409-1422 [Abstract] [Full Text]  
• Yerly, D., Heckerman, D., Allen, T. M., Chisholm, J. V. III, Faircloth, K., Linde, C. H., Frahm, N., Timm, J., Pichler, W. J., Cerny, A., Brander, C. (2008). Increased Cytotoxic T-Lymphocyte Epitope Variant Cross-Recognition and Functional Avidity Are Associated with Hepatitis C Virus Clearance. J. Virol. 82: 3147-3153 [Abstract] [Full Text]  
• Wolk, B., Gremion, C., Ivashkina, N., Engler, O. B., Grabscheid, B., Bieck, E., Blum, H. E., Cerny, A., Moradpour, D. (2005). Stable human lymphoblastoid cell lines constitutively expressing hepatitis C virus proteins. J. Gen. Virol. 86: 1737-1746 [Abstract] [Full Text]  
• Mason, R. D., Bowmer, M. I., Howley, C. M., Grant, M. D. (2005). Cross-Reactive Cytotoxic T Lymphocytes against Human Immunodeficiency Virus Type 1 Protease and Gamma Interferon-Inducible Protein 30. J. Virol. 79: 5529-5536 [Abstract] [Full Text]  
• Ahmad, A., Alvarez, F. (2004). Role of NK and NKT cells in the immunopathogenesis of HCV-induced hepatitis. J. Leukoc. Biol. 76: 743-759 [Abstract] [Full Text]  
• Gremion, C., Grabscheid, B., Wolk, B., Moradpour, D., Reichen, J., Pichler, W., Cerny, A. (2004). Cytotoxic T Lymphocytes Derived from Patients with Chronic Hepatitis C Virus Infection Kill Bystander Cells via Fas-FasL Interaction. J. Virol. 78: 2152-2157 [Abstract] [Full Text]  
• von Bergwelt-Baildon, M. S., Vonderheide, R. H., Maecker, B., Hirano, N., Anderson, K. S., Butler, M. O., Xia, Z., Zeng, W. Y., Wucherpfennig, K. W., Nadler, L. M., Schultze, J. L. (2002). Human primary and memory cytotoxic T lymphocyte responses are efficiently induced by means of CD40-activated B cells as antigen-presenting cells: potential for clinical application. Blood 99: 3319-3325 [Abstract] [Full Text]  
• Long, S. A., Quan, C., Van de Water, J., Nantz, M. H., Kurth, M. J., Barsky, D., Colvin, M. E., Lam, K. S., Coppel, R. L., Ansari, A., Gershwin, M. E. (2001). Immunoreactivity of Organic Mimeotopes of the E2 Component of Pyruvate Dehydrogenase: Connecting Xenobiotics with Primary Biliary Cirrhosis. J. Immunol. 167: 2956-2963 [Abstract] [Full Text]  
• Amrani, A., Serra, P., Yamanouchi, J., Trudeau, J. D., Tan, R., Elliott, J. F., Santamaria, P. (2001). Expansion of the Antigenic Repertoire of a Single T Cell Receptor upon T Cell Activation. J. Immunol. 167: 655-666 [Abstract] [Full Text]  
• Hudrisier, D., Riond, J., Burlet-Schiltz, O., von Herrath, M. G., Lewicki, H., Monsarrat, B., Oldstone, M. B. A., Gairin, J. E. (2001). Structural and Functional Identification of Major Histocompatibility Complex Class I-restricted Self-peptides as Naturally Occurring Molecular Mimics of Viral Antigens. POSSIBLE ROLE IN CD8+ T CELL-MEDIATED, VIRUS-INDUCED AUTOIMMUNE DISEASE. J. Biol. Chem. 276: 19396-19403 [Abstract] [Full Text]  

Home | Help | Feedback | Subscriptions | Archive | Search

TABLE OF CONTENTS